.svg){kind=small}
“…our lab recently performed a newly developed and intricate technique which isolated peripheral blood mononuclear cells for the measurement of intracellular drug concentrations. The results were recognised by the sponsor, and the scientist who developed the technique, to be outstanding and we have been asked to train other analytical laboratories on their behalf.”
.avif)
Latest news
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
